mHealth Spot

NexStem launches its VR headset and software to control devices through thought alone

NexStem headset

The medtech and robotics startup NexStem announced the finalization of its latest round of funding and the general availability of its NexStem Headsets and Wisdom SDK. This pioneer in the development of advanced end-to-end Brain-Computer Interfaces (BCIs) devices and applications, has cracked the code on improving the quality of the electroencephalography (EEG) signals harnessed by BCIs — a critical next step in inserting the human into the metaverse.

Spurred on by growing interest in NexStem’s innovative offering, this cash injection by investors BITS Spark Angels, InfoEdge, Maninder Gulati, and a host of angel investors will be used to fund the company’s growth and provide validation of this nascent field and technologies. NexStem will use this funding to facilitate the general availability of its award-winning headsets to the U.S., European, and APAC markets and to expand the company’s reach, build out its supply chain, and fund future research and development of its headsets and Wisdom-SDK software.

How does it work?

With a NexStem solution, developers and researchers can unlock an end-to-end experience with a next-generation headset at a highly affordable price point, and SDK-harnessing AI-algorithms that allow a user to engage with an application using their thoughts alone.

An inclusive end-to-end BCI solution researchers and developers can create BCI applications by:

Regarding future projects, NexStem has set itself an ambitious goal to develop one algorithm a month that allows humanity to understand the brain better. The team is looking to reduce the industry’s dependence on EEG data and signals, asserting that every other biosignal that originates from the body, such as muscular or even eye movements, can and should be tapped into. For example, heart, eye movements, oxygen saturation, perspiration, muscular movements, and even blood pressure cues.

Use cases extend to VR where instead of using a controller, users can use their thoughts to move around. Home automation integration allows users to “think” about switching on a television or adjusting the thermostat. Mental health is a qualitative use case, as the devices provide practitioners direct access to EEG data in a more accessible and affordable manner.

On the record

“We are creating the link between the EEG signal received by our headsets to the software needed to process and map this data to a multitude of applications”, said Siddhant Dangi, CEO, NexStem. “What differentiates us from other BCI providers is that, we provide the means for people to seamlessly communicate with machines through technologies that unlock the power of the human brain, to control actions and devices through thought. Our holistic approach to developing BCIs ensures we aren’t limited to a niche market. The funding we have received is validation not only of our technology, but that this is a market just waiting to break out into the mainstream.

“At NexStem, we are exploring the limitless use cases of BCIs in VR (virtual reality), mental health, and everyday use cases – paving the way for the human to become part of the Internet and the metaverse.”

“The biggest challenges facing BCIs today is that they are invasive, unwieldy, or ineffective, and building applications for them is difficult,” said Deepansh Goyal, CTO, NexStem. “We are unlocking the power of neural data ethically and responsibly through EEG analysis for medical and non-medical applications, stripping away BCI barriers to entry. NexStem does this by providing researchers, developers, and medical scientists with the tools needed to access quality EEG data they can transform into both medical and non-medical applications and use cases. Our goal is to help unlock the human brain and improve quality of life for all. Our vision is to become a complete toolkit for all the biosignals a body produces, and we continually develop new solutions to support this,” concluded Goyal.

The context

Recent research estimates that the global market for BCI devices will grow from $1.9 billion in 2021 to $3.3 billion by 2026. Further accelerating this growth is the fact that BCI use cases are growing from rudimentary health and static virtual reality applications to more immersive all-encompassing experiences.

The use of extended reality (XR) technologies — including virtual reality (VR) — in healthcare has been growing in recent years. To get more information about the latest trends and key players, check out our report “XR in Healthcare” which you can order today from our sister website DHbriefs.com.

Exit mobile version